110 related articles for article (PubMed ID: 14610128)
1. [Alpha]B-crystallin genotype has impact on the multiple sclerosis phenotype.
van Veen T; van Winsen L; Crusius JB; Kalkers NF; Barkhof F; Peña AS; Polman CH; Uitdehaag BM
Neurology; 2003 Nov; 61(9):1245-9. PubMed ID: 14610128
[TBL] [Abstract][Full Text] [Related]
2. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
Stoevring B; Frederiksen JL; Christiansen M
Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.
Schrijver HM; Hooper-van Veen T; van Belzen MJ; Crusius JB; Peña AS; Barkhof F; Polman CH; Uitdehaag BM
Eur J Immunogenet; 2004 Jun; 31(3):133-40. PubMed ID: 15182327
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
van Winsen LM; Hooper-van Veen T; van Rossum EF; Koper JW; Barkhof F; Polman CH; Uitdehaag BM
J Neuroimmunol; 2007 May; 186(1-2):150-5. PubMed ID: 17395275
[TBL] [Abstract][Full Text] [Related]
5. Association of Alpha B-Crystallin (CRYAB) genotypes with breast cancer susceptibility in Taiwan.
Su CH; Liu LC; Hsieh YH; Wang HC; Tsai CW; Chang WS; Ho CY; Wu CI; Lin CH; Lane HY; Bau DT
Cancer Genomics Proteomics; 2011; 8(5):251-4. PubMed ID: 21980040
[TBL] [Abstract][Full Text] [Related]
6. CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.
Sun C; Sedimbi SK; Ashok AK; Sanjeevi CB;
Hum Immunol; 2012 Jul; 73(7):759-66. PubMed ID: 22537749
[TBL] [Abstract][Full Text] [Related]
7. Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.
Matiello M; Weinshenker BG; Atkinson EJ; Schaefer-Klein J; Kantarci OH
Mult Scler; 2011 May; 17(5):634-6. PubMed ID: 21239413
[TBL] [Abstract][Full Text] [Related]
8. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis.
van Veen T; Crusius JB; van Winsen L; Xia B; Barkhof F; Salvador Peña A; Polman CH; Uitdehaag BM
J Neuroimmunol; 2003 Jul; 140(1-2):188-93. PubMed ID: 12864988
[TBL] [Abstract][Full Text] [Related]
11. The SH2D2A gene and susceptibility to multiple sclerosis.
Lorentzen AR; Smestad C; Lie BA; Oturai AB; Akesson E; Saarela J; Myhr KM; Vartdal F; Celius EG; Sørensen PS; Hillert J; Spurkland A; Harbo HF
J Neuroimmunol; 2008 Jul; 197(2):152-8. PubMed ID: 18554728
[TBL] [Abstract][Full Text] [Related]
12. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
[TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene.
Tienari PJ; Wikström J; Sajantila A; Palo J; Peltonen L
Lancet; 1992 Oct; 340(8826):987-91. PubMed ID: 1383661
[TBL] [Abstract][Full Text] [Related]
14. Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
Goertsches R; Comabella M; Navarro A; Perkal H; Montalban X
J Neuroimmunol; 2005 Jul; 164(1-2):140-7. PubMed ID: 15913795
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
[TBL] [Abstract][Full Text] [Related]
16. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF.
Palacio LG; Rivera D; Builes JJ; Jiménez ME; Salgar M; Anaya JM; Jiménez I; Camargo M; Arcos-Burgos M; Sánchez JL
Mult Scler; 2002 May; 8(3):249-55. PubMed ID: 12120698
[TBL] [Abstract][Full Text] [Related]
18. Promoter polymorphism of IL-10 and severity of multiple sclerosis.
Luomala M; Lehtimäki T; Huhtala H; Ukkonen M; Koivula T; Hurme M; Elovaara I
Acta Neurol Scand; 2003 Dec; 108(6):396-400. PubMed ID: 14616291
[TBL] [Abstract][Full Text] [Related]
19. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
20. Association of alpha B-crystallin genotypes with oral cancer susceptibility, survival, and recurrence in Taiwan.
Bau DT; Tsai CW; Lin CC; Tsai RY; Tsai MH
PLoS One; 2011; 6(9):e16374. PubMed ID: 21915251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
